Table 1.
Baseline donor and recipient demographics and allograft related factors (n=2460).
| Baseline characteristics | Included pairs (n=1,869) | n | Excluded pairs (n=591) | n | P-value |
|---|---|---|---|---|---|
| Duration of brain death period (hours) | 10.6 (8.9–12.5) | 1,869 | N/A | 591 | N/A |
| Donor gender (Male) | 833 (44.6%) | 1,869 | 313 (53.0%) | 591 | .000 |
| Donor age (years) | 54 (45–63) | 1,869 | 51 (42–58) | 591 | .000 |
| Donor body mass index (kg/m2) | 24.5 (22.5–26.9) | 1,869 | 25.1 (23.3–27.8) | 591 | .000 |
| Expanded criteria donor | 696 (37.2%) | 1,869 | 157 (26.6%) | 591 | .000 |
| Donor history of hypertension | 505 (28.0%) | 1,806 | 179 (42.3%) | 423 | .000 |
| Donor hypotensive period(s) | 658 (37.3%) | 1,762 | 122 (34.2%) | 357 | .252 |
| Donor history of diabetes mellitus | 24 (1.3%) | 1,859 | 0 (0.0%) | 19 | .618 |
| Donor history of cardiac arrest | 449 (24.4%) | 1,843 | 76 (20.1%) | 378 | .064 |
| Donor use of inotropic medication | 1,616 (86.5%) | 1,869 | 22 (95.7%) | 23 | .049 |
| Donor cause of death: stroke | 587 (31.4%) | 1,869 | 163 (27.6%) | 591 | .073 |
| Donor cause of death: trauma | 290 (15.5%) | 1,869 | 89 (15.1%) | 591 | .789 |
| Donor lowest creatinine (μmol/L) | 64 (50–100) | 1,868 | 69 (53–104) | 591 | .707 |
| Recipient gender (Male) | 1,151 (61.6%) | 1,869 | 300 (50.8%) | 591 | .000 |
| Recipient age (years) | 57 (45–65) | 1,869 | 54 (44–61) | 591 | .000 |
| Recipient body mass index (kg/m2) | 25.4 (22.8–28.4) | 1,725 | 24.8 (22.2–28.1) | 564 | .181 |
| Recipient dialysis duration (years) | 3.67 (2.42–4.99) | 1,702 | 2.98 (1.90–4.58) | 542 | .017 |
| Cold ischemia time (hours) | 14.6 (11.5–19.0) | 1,665 | 18.0 (14.5–22.7) | 551 | .000 |
| Anastomosis time (minutes) | 33 (26–40) | 1,662 | 32 (25–40) | 534 | .376 |
| Number of HLA mismatches | 3 (2–4) | 1,859 | 2 (0–3) | 589 | .000 |
| Delayed graft function | 277 (17.5%) | 1,583 | 82 (16.0%) | 513 | .429 |
| Acute graft rejection within 1 year | 110 (5.9%) | 1,869 | 38 (6.4%) | 591 | .628 |
| Graft failure | 293 (15.7%) | 1,869 | 100 (16.9%) | 591 | .472 |
Values are expressed as the median (25th–75th percentile), unless stated otherwise. HLA – human leukocyte antigen.